Literature DB >> 8390036

flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1.

L S Levy1, P A Lobelle-Rich, J Overbaugh.   

Abstract

LC-FeLV is a myc-containing strain of feline leukemia virus which induces thymic lymphosarcoma in the domestic cat with short latency. A locus in feline DNA, termed flvi-2, is commonly interrupted in naturally occurring and experimentally induced thymic lymphosarcomas containing LC-FeLV; thus, interruption of a gene encoded by flvi-2 may cooperate with the myc oncogene in the induction of T-cell tumors by LC-FeLV. Clones homologous to flvi-2 have been isolated from a normal human thymus cDNA library. Nucleotide sequence analysis of the cDNA clones demonstrates that flvi-2 encodes bmi-1, a gene previously identified as a target for MoMuLV integration and as a myc-collaborator in retrovirally-induced B-cell lymphomas in E mu-myc transgenic mice. In feline thymic lymphomas, retroviral integrations occur downstream of the gene, and result in enhanced expression of a bmi-1 transcript of normal size. These findings demonstrate the interruption of bmi-1 in natural as well as experimentally induced tumors, implicate the activation of bmi-1 in the induction of T-cell as well as B-cell lymphoma, and support the premise that bmi-1 functions as a myc collaborator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390036

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.

Authors:  Kristiina Joensuu; Jaana Hagström; Marjut Leidenius; Caj Haglund; Leif C Andersson; Hannu Sariola; Päivi Heikkilä
Journal:  Virchows Arch       Date:  2011-06-03       Impact factor: 4.064

2.  The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.

Authors:  J Pantginis; R M Beaty; L S Levy; J Lenz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?

Authors:  Suvi Renkonen; Valtteri Häyry; Päivi Heikkilä; Ilmo Leivo; Caj Haglund; Antti A Mäkitie; Jaana Hagström
Journal:  Virchows Arch       Date:  2010-11-27       Impact factor: 4.064

4.  Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

Authors:  S K Ghosh; D V Faller
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.

Authors:  Chassidy Johnson; Patricia A Lobelle-Rich; Adriane Puetter; Laura S Levy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.

Authors:  J L Rohn; M S Moser; S R Gwynn; D N Baldwin; J Overbaugh
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.

Authors:  C Tsatsanis; R Fulton; K Nishigaki; H Tsujimoto; L Levy; A Terry; D Spandidos; D Onions; J C Neil
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity.

Authors:  K J Cohen; J S Hanna; J E Prescott; C V Dang
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 9.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Authors:  Lora W Forman; Ruma Pal-Ghosh; Remco A Spanjaard; Douglas V Faller; Sajal K Ghosh
Journal:  FEBS Lett       Date:  2009-03-29       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.